	ZNF468 Exhibits Oncogenic Activity by Regulating Unexplored ZNF707 in Breast Cancer. J Gene Med Mahapatra MK, Bansal S, Makwana SH, Ghosh S, Nag A, Shrivastava SK, Maheshwari R, Mandal CC. PMID: 42219449 [PubMed - indexed for MEDLINE]
	Assessing Delay Patterns in Diagnosis and Care Among Breast Cancer Patients in Ethiopia. Cancer Rep (Hoboken) Gebremariam MS, Kejela S, Asres YA, Beyene EC, Bukate TA, Ojamo MM, Asfaw KG, Negassa MT, Legesse AT. PMID: 42219283 [PubMed - indexed for MEDLINE]
	A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY Trial. Ann Oncol Kim GM, Jung KH, Jeung HC, Lee J, Lee KS, Im SA, Kang SY, Kim SH, Kim HJ, Park KH, Chae YS, Koh SJ, Cho EK, Park KU, Lee SS, Kim JY, Choi IS, Baek SK, Moon YW, Kim SG, Lim ST, Lee KH, Kim HJ, Kim MH, Kim KH, Kim SI, Park S, Park HS, Kim JY, Kim YB, Kim SB, Ahn JH, Jeong JH, Kim JH, Jeong J, Park WC, Sim SH, Lee K, Nam CM, Park S, Paik S, Sohn J, Korean Cancer Study Group (KCSG). PMID: 42218963 [PubMed - as supplied by publisher]
	The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions. Cancer Treat Rev Zotano ÁG, Allweis TM, Foerster R, Palmieri C, Gluz O, Chia S, Sotiriou C, Bianchini G. PMID: 42218834 [PubMed - as supplied by publisher]
	Expert Opinions on Postoperative Complications in Breast Cancer Surgery After Neoadjuvant Chemotherapy: A Descriptive Study Through Structured Interviews With Surgeons in Austria. Breast J Leser C, Eisl R, Dorffner G, Kabashi F, Gschwantler-Kaulich D, Deutschmann C, Danzinger S, Koller R. PMID: 42218781 [PubMed - indexed for MEDLINE]
	Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study. JAMA Oncol Shieh Y, Heise RS, Madlensky L, Sabacan LP, Soto IA, Fiscalini AS, Ross K, Goodman D, Blanco A, Brain S, Heditsian DM, Moya J, Fergus KB, Olopade OI, Scheuner MT, Eklund M, Ziv E, Tice JA, van 't Veer L, Esserman LJ, Athena Breast Health Network and WISDOM Study Investigators and Advocate Partners. PMID: 42218736 [PubMed - as supplied by publisher]
	Exosomal lncRNAs as molecular switches driving macrophage-tumor co-evolution in breast cancer. Clin Exp Med Javadian M, Zeinali T, Rajabi M, Mehrasa Z, Boogari M, Ramezani F, Samaeinasab S, Mahmoudi Z, Hakimi H, Sabzehban R, Najafi K, Esmaeili K, Khaksarhaghani Z, Tahmasebi S, Rezaei R. PMID: 42218707 [PubMed - as supplied by publisher]
	Small interfering RNA (siRNA)-based targeting breast cancer therapy. Discov Oncol Talebi A, Khorrami A, Oruji F, Shabani S, Hajazimian S, Nasiri H, Khansalar S, Isazadeh A, Akbari M. PMID: 42218706 [PubMed - as supplied by publisher]
	Premedication with steroids in breast cancer - supportive treatment or tumour growth promotion? Magy Onkol Butz H, Oláh A, Patócs A. PMID: 42218678 [PubMed - indexed for MEDLINE]
	Development and external validation of multiple machine learning-based models for breast cancer-specific survival prediction in postoperative patients with invasive breast cancer: a study based on the SEER database and an external cohort. BMC Cancer Liu S, Liu J, Li D, Mo Q. PMID: 42218459 [PubMed - as supplied by publisher]
	Nipple aspirate fluid as aÂ proximal breast liquid biopsy platform: advancing precision risk management in breast cancer. Clin Proteomics Guo S, Liu J, Zheng H, Wu X. PMID: 42218386 [PubMed - as supplied by publisher]
	Multi-ancestry transcriptome-wide association studies uncover insights into breast cancer genetics and biology. Nat Commun Ping J, Jia G, Cai Q, Guo X, Wang J, Tao R, Li B, Bauer JA, Xie Y, Ambs S, Barnard ME, Chen Y, Choi JY, Gao YT, Garcia-Closas M, Gu J, Hu JJ, Iwasaki M, John EM, Kweon SS, Li CI, Matsuda K, Matsuo K, Nathanson KL, Nemesure B, Olopade OI, Pal T, Park SK, Park B, Press MF, Sanderson M, Sandler DP, Yao S, Zheng Y, Ahearn T, Brewster AM, Falusi A, Hennis AJM, Ito H, Kubo M, Lee ES, Makumbi T, Mapoko BSE, Noh DY, O'Brien KM, Ojengbede O, Olshan AF, Park MH, Reid S, Yamaji T, Zirpoli G, Butler EN, Huang M, Low SK, Obafunwa J, Weinberg CR, Zhang H, Zhao H, Ambrosone CB, Cote ML, Huo D, Haiman CA, Kang D, Palmer JR, Troester MA, Shu XO, Long J, Zheng W. PMID: 42218145 [PubMed - as supplied by publisher]
	Unravelling the mystery of hypoxia-induced miRNAs in breast cancer: A molecular cross-talk driving tumour progression and therapy resistance. Mol Aspects Med Sharma N, Yadav V, Sinha S, Kumari L, Sethi A, Marcus S, Pratap Singh M, Kaur S, Garg N, Pathak A, Vellingir B, Kumar S. PMID: 42217842 [PubMed - as supplied by publisher]
	Circular RNA-centered regulatory networks in breast cancer: From ceRNA crosstalk to immune microenvironment reprogramming. Gene Wang J, Tian Y. PMID: 42217688 [PubMed - as supplied by publisher]
	Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(â€ ). Ann Oncol de Azambuja E, Barrios CH, Bartsch R, Curigliano G, Dent R, Gennari A, Loi S, Paluch-Shimon S, Pistilli B, Saura C, Schmid P, Spanic T, Toi M, Tolaney SM, Harbeck N, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. PMID: 42217581 [PubMed - as supplied by publisher]
	Estimating overall survival for breast cancer in Ghana: A time-to-event meta-analysis. Cancer Epidemiol Darko K, Ajayi-Majebi G, Marfo K, Agbemavi-Kudufia LA, Hagan HR, Nsaful J. PMID: 42217387 [PubMed - as supplied by publisher]
	Exploring shear-wave elastography and apparent diffusion coefficient in breast lesion characterization: diagnostic accuracy and inter-modality correlation. Radiol Med Aricò FM, Portaluri A, Arena P, Sofia C, Condorelli E, Catanzariti F, Zuccalà V, Berretta M, Ascenti G, Marino MA. PMID: 42217149 [PubMed - as supplied by publisher]
	Single axillary incision for minimal access (endoscopic or robotic-assisted) nipple sparing mastectomy: axillary crease or lateral chest wall incision? J Robot Surg Koh CH, Kao WP, Periasammy D, Lee YY, Lai HW. PMID: 42216981 [PubMed - indexed for MEDLINE]
	DNA Damage Repair Pathways and Targeted Therapy for Doxorubicin-Resistant Breast Cancer. Front Biosci (Landmark Ed) Wu Y, Li X, Wang W, Liu SB, Li X. PMID: 42216534 [PubMed - indexed for MEDLINE]
	From Technological Innovation to Clinical Translation: Progress and Challenges in 3D Bioprinting for the Development of Breast Cancer Bone Metastasis Models. Adv Healthc Mater Miao L, Jiang D, Zhang X, Kang Y. PMID: 42216436 [PubMed - as supplied by publisher]

Articles 1 - 20 / 218322

Page 1 of 10917



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy